A Relative Bioavailability Study Between Two Formulations Of Sildenafil Citrate
Summary
The purpose of this study is to perform a relative bioavailability study between two formulations of sildenafil citrate.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-03
- Completion
- 2010-03
Outcome
Mixed primary results
registry Test 1: 100 mg Chewable, Without Water vs Reference: 100 mg Coated, With Water; ratio between geometric means 98.68 (90% CI 92.03 to 105.82); ANOVA NCT00904748 ↗
registry Test 2: 100 mg Chewable, With Water vs Reference: 100 mg Coated, With Water; ratio between geometric means 97.23 (90% CI 90.67 to 104.26); ANOVA NCT00904748 ↗
registry Test 1: 100 mg Chewable, Without Water vs Reference: 100 mg Coated, With Water; ratio between geometric means 80.83 (90% CI 72.38 to 90.26); ANOVA NCT00904748 ↗
registry Test 2: 100 mg Chewable, With Water vs Reference: 100 mg Coated, With Water; ratio between geometric means 78.76 (90% CI 70.53 to 87.96); ANOVA NCT00904748 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sildenafil | Unknown | 100 mg | — |